Corporate news - Gerresheimer

公司新闻

Organic revenue growth in 2023: +10.4%   Organic adjusted EBITDA growth in 2023: +17.5%   Favorable product mix boosts profitability  High order…
阅读更多
Subcutaneous administration of oncology drugs with digital therapy support   Integrating Gx SensAir drug delivery device with Aptar's Digital…
阅读更多
Duesseldorf, December 5, 2023. Guido Pickert will join Gerresheimer AG, an innovative system and solution provider and a global partner for the…
阅读更多
Agreement signed with PNE AG to supply around 35 GWh per year  CO2 emissions to be cut by around 18,000 t   Gerresheimer increases share…
阅读更多
Significant expansion of production capacities for RTF syringes for the North American market Investment volume of around 100 million Euros Düs…
阅读更多
Gerresheimer among the top 5% of assessed businesses Total score increases to 72/100 points Status demonstrates consistent implementation of CSR…
阅读更多
Organic revenue growth of 12.6% in the first nine months of the financial year 2023 Adjusted EBITDA up organically by 20.6% Order intake at record…
阅读更多
SBTi provides science-based framework for companies’ climate action targets Gerresheimer to have CO2 reduction targets validated by SBTi Plans in…
阅读更多
Organic revenue growth of 16.6% in first half of 2023 Adjusted EBITDA up 23.0% organically Production capacities expanded in Europe, the United…
阅读更多

联系我们!

您有什么问题吗?
我们很乐意帮助您!

邮箱: info-china
电话:186 6119 5281 (微信同号)

留言

工作机会